These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37980622)

  • 1. Treating Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation.
    Eisenberger J; Somer S; Ram E; Nachum E; Frogal J; Levin S; Lavee J; Sternik L; Morgan J
    Isr Med Assoc J; 2023 Nov; 25(11):757-759. PubMed ID: 37980622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.
    Lee CL; Colombo PC; Eisenberger A; Diuguid D; Jennings DL; Han J; Salna MP; Takeda K; Kurlansky PA; Yuzefpolskaya M; Garan AR; Naka Y; Takayama H
    Ann Thorac Surg; 2018 Jan; 105(1):122-128. PubMed ID: 28987395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis during off pump LVAD placement in a patient with heparin induced thrombocytopenia using bivalirudin.
    Awad H; Bryant R; Malik O; Dimitrova G; Sai-Sudhakar CB
    J Cardiothorac Surg; 2013 Apr; 8():115. PubMed ID: 23628179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Heparin-Induced Thrombocytopenia Using Plasmapharesis in Patients Undergoing HeartMate 3 Left Ventricular Assist Device.
    Naqvi SY; Jawaid A; Dao B; Falvey J; Vidula H; Gosev I; Thomas S
    ASAIO J; 2022 Sep; 68(9):e152-e155. PubMed ID: 34967780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia.
    Hillebrand J; Sindermann J; Schmidt C; Mesters R; Martens S; Scherer M
    J Artif Organs; 2015 Dec; 18(4):291-9. PubMed ID: 26044781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
    Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
    Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
    Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
    Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful implantation of a left ventricular assist device in a patient with heparin-induced thrombocytopenia and thrombosis.
    Garland C; Somogyi D
    J Extra Corpor Technol; 2014 Jun; 46(2):162-5. PubMed ID: 25208434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Triple HIT: Perioperative Management of Heparin-Induced Thrombocytopenia Using Plasma Exchange, Intravenous Immunoglobulin, and Protamine Infusion for Left Ventricular Assist Device Implantation.
    Liu VC; Klompas AM; Stulak JM; Yalamuri SM
    J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1715-1719. PubMed ID: 33933367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia.
    Gernhofer YK; Ross M; Khoche S; Pretorius V
    J Cardiothorac Surg; 2018 Apr; 13(1):30. PubMed ID: 29665860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful HeartMate 3 LVAD implantation in a patient with active heparin-induced thrombocytopaenia with thrombosis using pre-implantation plasmapheresis and intraoperative continuous prostacyclin.
    Grinstein J; Molina EJ; Sheikh FH
    Interact Cardiovasc Thorac Surg; 2021 Jun; 33(1):161-162. PubMed ID: 33575742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
    Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
    J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified technique for implantation of the HeartWare™ left ventricular assist device when using bivalirudin anticoagulation in patients with acute heparin-induced thrombocytopenia.
    Morshuis M; Boergermann J; Gummert J; Koster A
    Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):225-6. PubMed ID: 23628649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.
    Benken ST; Tillman N; Dajani S; Shah A; Thomas T
    J Cardiothorac Surg; 2014 Mar; 9():55. PubMed ID: 24656312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study.
    Puri K; Tunuguntla HP; Hensch LA; Loh J; Hui SK; Razavi A; Tume SC; Humlicek TJ; Denfield SW; Spinner JA; Choudhry S; Price JF; Dreyer WJ; Adachi I; Teruya J
    Pediatr Crit Care Med; 2022 Oct; 23(10):e465-e475. PubMed ID: 35687091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients.
    Koster A; Huebler S; Potapov E; Meyer O; Jurmann M; Weng Y; Pasic M; Drews T; Kuppe H; Loebe M; Hetzer R
    Ann Thorac Surg; 2007 Jan; 83(1):72-6. PubMed ID: 17184633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.
    Faella KH; Whiting D; Fynn-Thompson F; Matte GS
    J Extra Corpor Technol; 2016 Mar; 48(1):39-42. PubMed ID: 27134308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.